T. Julian

发表

MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer.

C. Gatsonis, C. Lehman, C. Kuhl, 2007, The New England journal of medicine.

Abstract S1-10: Association between the 21-gene recurrence score (RS) and benefit from adjuvant paclitaxel (Pac) in node-positive (N+), ER-positive breast cancer patients (pts): Results from NSABP B-28

T. Julian, S. Paik, G. Tang, 2012 .

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

T. Julian, J. Costantino, N. Wolmark, 2007, The Lancet. Oncology.

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

T. Julian, J. Costantino, N. Wolmark, 2010, The Lancet. Oncology.

Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers.

T. Julian, N. Wolmark, L. Gu, 2001, Cytometry.

Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy

K. Hunt, T. Julian, J. Boughey, 2018, Supportive Care in Cancer.

Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection

Norman Wolmark, Takamaru Ashikaga, T. Julian, 2010, Journal of surgical oncology.

Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30

T. Julian, S. Swain, P. Ganz, 2018, Journal of the National Cancer Institute.

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

T. Julian, J. Costantino, N. Wolmark, 2016, The Lancet.

OT2-06-02: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs Partial Breast Irradiation (PBI) for Women with Stage 0, 1, or 2 Breast Cancer: NSABP B-39/RTOG 0413.

W. Curran, T. Julian, F. Vicini, 2011 .

Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches.

T. Julian, J. Costantino, N. Wolmark, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006)

R. Jagsi, T. Julian, P. Ganz, 2021, Breast Cancer Research and Treatment.

Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial.

T. Julian, J. Skelly, N. Wolmark, 2009, Journal of the National Cancer Institute.

Axillary recurrences following positive sentinel lymph node biopsy with individual tumor cells or micrometastases and no axillary dissection.

T. Julian, K. Erb, Hilary M Shapiro-Wright, 2010, Breast disease.

does P redicting Positive Nonsentinel Nodes answ er the Question of axillar y dissection and P rovide a Benefit

T. Julian, C. Slomski, 2012 .

CAGS and ACS Evidence Based Reviews in Surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis.

T. Julian, Randal L. Croshaw, I. Olivotto, 2012, Canadian journal of surgery. Journal canadien de chirurgie.

Does predicting positive nonsentinel nodes answer the question of axillary dissection and provide a benefit?.

T. Julian, C. Slomski, 2012, Journal of the National Cancer Institute.

Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?

A. Giuliano, T. Julian, M. Morrow, 2012, Clinical & Experimental Metastasis.

Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors.

R. Simmons, A. Giuliano, T. Julian, 2007, American Journal of Surgery.

Is Partial Breast Irradiation a Safe and Effective Treatment Approach for Women with Early-Stage Breast Cancer?

T. Julian, F. Vicini, D. Arthur, 2013, Current Breast Cancer Reports.

Comparison of conservative management techniques in the re-treatment of ipsilateral breast tumor recurrence.

T. Julian, Yongbok Kim, D. Parda, 2011, Brachytherapy.

Reduction in radiation-induced morbidity by use of an intercurrent boost in the management of early-stage breast cancer.

T. Julian, D. Parda, M. Trombetta, 2010, International journal of radiation oncology, biology, physics.

Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002.

H. Bartelink, C. Coleman, A. Giuliano, 2004, Journal of the National Cancer Institute.

Short-Term Follow-Up Mammography in Breast Conservation Therapy Likely Leads to Unnecessary Downstream Workup: A Longitudinal Study.

T. Julian, M. Trombetta, S. Karlovits, 2017, International journal of radiation oncology, biology, physics.

COMMENTARY Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda, MD,

H. Bartelink, C. Coleman, A. Giuliano, 2004 .

Abstract S3-02: NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC) in patients (pts) with node-negative breast cancer

T. Julian, C. Geyer, D. Wickerham, 2015 .

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

G. Babiera, T. Julian, G. Sledge, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of occult metastases on survival in node-negative breast cancer.

Donald L. Weaver, Stewart J. Anderson, David N. Krag, 2011, The New England journal of medicine.

Racial disparity in distant recurrence‐free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials

T. Julian, T. Rohan, J. Sparano, 2022, Cancer.

Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer.

W. Curran, M. Scheier, H. Kuerer, 2019, Journal of Clinical Oncology.

A simple way to finish a continuous laparoscopic suture

T. Julian, R. E. Schwarz, 1995, Surgical Endoscopy.

Breast conservation surgery and radiation for a patient with synchronous primary breast cancers and BRCA1/BRCA2 positivity: is mastectomy required?

T. Julian, M. Trombetta, K. Kotinsley, 2011, Journal of Radiotherapy in Practice.

Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) trial

N. Hylton, C. Gatsonis, C. Lehman, 2005, Journal of surgical oncology.

Image-detected breast cancer: state of the art diagnosis and treatment.

Roland Holland, Henry M Kuerer, H. Kuerer, 2005, Journal of the American College of Surgeons.

Abstract S2-05: 10-yr follow-up results of occult detected sentinel node disease: NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients

T. Julian, J. Costantino, N. Wolmark, 2013 .

Boost Radiotherapy for the Treatment of Ductal Carcinoma In Situ Remains Controversial

T. Julian, S. Duggal, Amelia Tower, 2015 .

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

T. Julian, I. Nagtegaal, S. Paik, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term outcomes after invasive breast tumor recurrence (IBTR) in women with DCIS in NSABP B-17 and B-24

T. Julian, J. Costantino, N. Wolmark, 2007 .

Primary results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) versus tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy.

T. Julian, J. Costantino, N. Wolmark, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary results , NSABP B-35 / NRG Oncology : A clinical trial of anastrozole vs tamoxifen in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy A randomized clinical trial

T. Julian, J. Costantino, R. Margolese, 2016 .

Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial

T. Julian, N. Wolmark, K. Siziopikou, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

W. McCaskill-Stevens, T. Julian, J. Costantino, 2013, Breast Cancer Research and Treatment.

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

T. Julian, J. Costantino, N. Wolmark, 2011, Journal of the National Cancer Institute.

Is boost therapy necessary in the treatment of DCIS

T. Julian, F. Vicini, J. Costantino, 2008 .

Partial-Breast Irradiation: Review of Modern Trials

T. Julian, F. Vicini, C. Shah, 2019, Current Breast Cancer Reports.

Correlation of the use of axillary ultrasound and lymph node needle biopsy with surgical lymph node pathology in patients with invasive breast cancer.

T. Julian, W. Poller, M. Cowher, 2008, American journal of surgery.

Practice patterns of sentinel node biopsy at five comprehensive cancer centers.

T. Julian, D. Krag, 2003, Journal of the National Cancer Institute.

Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients.

T. Julian, J. Costantino, N. Wolmark, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

10-yr follow-up results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients.

T. Julian, J. Costantino, N. Wolmark, 2010 .

Atypical squamous metaplasia of seromas in breast needle aspirates from irradiated lumpectomy sites: A potential pitfall for false‐positive diagnoses of carcinoma

T. Julian, J. Silverman, C. Sturgis, 2002, Diagnostic cytopathology.

Long-term Cosmesis After Lumpectomy and Brachytherapy in the Management of Carcinoma of the Previously Irradiated Breast

T. Julian, Yongbok Kim, M. Miften, 2009, American journal of clinical oncology.

An Update of the Credentialing Process for the NRG Oncology NSABP B-51 / RTOG 1304 Phase 3 Randomized Clinical Trial

W. Curran, J. Galvin, T. Julian, 2015 .

Abstract S2-1: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from the ACOSOG Z1071 trial

S. Mclaughlin, T. Julian, T. Buchholz, 2012 .

Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study

T. Julian, T. George, R. Paulus, 2022, JMIR cancer.

The use of the MammoSite balloon applicator in re-irradiation of the breast.

T. Julian, Yongbok Kim, M. Miften, 2008, Brachytherapy.

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study

T. Julian, C. Geyer, N. Wolmark, 2014, Breast Cancer Research and Treatment.

Prognostic impact of the 21-gene recurrence score (RS) on disease-free and overall survival of node-positive, ER-positive breast cancer patients (pts) treated with adjuvant chemotherapy: Results from NSABP B-28.

T. Julian, S. Paik, G. Tang, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Presentation of Thrombosed Greenfield Filters

T. Julian, R. Kolachalam, 1990 .

Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)

T. Julian, C. Geyer, P. Ward, 2021, Breast Cancer Research and Treatment.

Accelerated partial-breast irradiation: trial by media or by science?

T. Julian, F. Vicini, M. Anscher, 2012, International journal of radiation oncology, biology, physics.

Improvements in critical dosimetric endpoints using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation: preliminary dosimetric findings of a phase iv trial.

T. Julian, F. Vicini, D. Todor, 2011, International journal of radiation oncology, biology, physics.

Magnetic resonance imaging detection and wire localization of an ‘occult’ breast cancer

T. Julian, P. Davis, K. Mccarty, 2004, Breast Cancer Research and Treatment.

The allegheny general modification of the Harvard Breast Cosmesis Scale for the retreated breast.

T. Julian, Yongbok Kim, D. Parda, 2009, Oncology.

Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer

W. Curran, M. Scheier, G. Gustafson, 2019, General Session Abstracts.

Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial.

W. Curran, T. Julian, F. Vicini, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inflammatory aneurysms of the abdominal aorta.

A. Peitzman, D. Steed, M. Webster, 1989, Archives of surgery.

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

Lawrence B Marks, Julia White, Benjamin D Smith, 2009, Journal of the American College of Surgeons.

Report of the Working Groups on Breast MRI: Report of the Biopsy and Intervention Working Group

T. Julian, S. Harms, V. Klimberg, 2004, The breast journal.

An experimental study of the mechanical response of frozen biological tissues at cryogenic temperatures.

T. Julian, N. Wolmark, P. Steif, 1996, Cryobiology.

Safety Profile of Amnion-Derived Cellular Cytokine Solution (ACCS) Following Topical Skin Application in Patients Receiving Breast Radiotherapy

T. Julian, D. Wickerham, M. Trombetta, 2015, Eplasty.

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

T. Julian, T. Whelan, T. Buchholz, 2009, International journal of radiation oncology, biology, physics.

Limited-Field and Whole-Breast Hypofractionated Radiotherapy

T. Julian, F. Vicini, D. Arthur, 2012 .

In Reply to Dr. Beal et al

T. Julian, T. Whelan, T. Buchholz, 2010 .

Breast cancer and the NSABP-B32 sentinel node trial

T. Julian, D. Krag, S. Harlow, 2004, Breast cancer.

Dosimetric Improvements in Balloon Based Brachytherapy Using the Contura® Multi-Lumen Balloon (MLB) Catheter to Deliver Accelerated Partial Breast Irradiation

T. Julian, F. Vicini, D. Todor, 2010, Journal of contemporary brachytherapy.

Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial bre

W. Curran, T. Julian, F. Vicini, 2010, International journal of radiation oncology, biology, physics.

Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.

T. Julian, M. Trombetta, Michael Hall, 2014, Brachytherapy.

Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

T. Julian, J. Kopec, J. Costantino, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Local failure and acute radiodermatological toxicity in patients undergoing radiation therapy with and without postmastectomy chest wall bolus: Is bolus ever necessary?

T. Julian, M. Trombetta, R. Wegner, 2017, Practical radiation oncology.

The management of aortoenteric and paraprosthetic fistulae.

R. Higgins, A. Peitzman, D. Steed, 1990, The Journal of cardiovascular surgery.

Thoracoscopic pancreatic denervation for pain control in irresectable pancreatic cancer

T. Julian, R. Landreneau, R. Keenan, 1993 .

Obstruction of the pancreatic duct by a granular cell tumor

T. Julian, G. Sekas, T. Talamo, 1988, Digestive Diseases and Sciences.

Mammary fat necrosis following radiotherapy in the conservative management of localized breast cancer: does it matter?

T. Julian, D. Parda, M. Trombetta, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

S. Mclaughlin, H. Kuerer, K. Hunt, 2013, JAMA.

Malfunctioning Peritoneal Dialysis Catheter Repaired by Laparoscopic Surgery

T. Julian, F. Bruns, D. Fraley, 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology

T. Julian, S. Paik, G. Tang, 2018, Breast Cancer Research and Treatment.

Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.

J F Silverman, T. Julian, N. Wolmark, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Closure of large postradiation vesicovaginal fistula with rectus abdominis myofascial flap.

T. Julian, K. Narayanan, R. Salup, 1994, Urology.

Ductal carcinoma in situ: biology, diagnosis, and new therapies.

T. Julian, M. Valenzuela, 2007, Clinical breast cancer.

Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: A systematic review and meta-analysis

T. Julian, J. Robin, Shivani Duggal, 2013 .

Breast Brachytherapy: Brachytherapy in the Management of Ipsilateral Breast Tumor Recurrence

T. Julian, J. Hannoun-levi, M. Trombetta, 2016 .

Accelerated Partial Breast Irradiation After Conservative Surgery for Breast Cancer

A. Giuliano, H. Kuerer, T. Julian, 2004, Annals of surgery.

Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer

D. Berry, E. Feuer, W. Sauerbrei, 2018, Journal of the National Cancer Institute.

Evaluation of the safety of end-to-end (EEA) stapling anastomoses across linear stapled closures.

T. Julian, M. Ravitch, Thomas B. Julian, 1984, The Surgical clinics of North America.

Venous aneurysm after polytetrafluoroethylene arteriovenous dialysis fistula.

T. Julian, H. Moosa, R. R. Johnson, 1989, Journal of vascular surgery.

Polytetrafluoroethylene or saphenous vein as a femoropopliteal bypass graft?

T. Julian, J. Stremple, J. Loubeau, 1982, The Journal of surgical research.

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

T. Julian, Randal L. Croshaw, K. Erb, 2011, International journal of breast cancer.

A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: A trial of the ECOG-ACRIN Research Group (E2108).

G. Babiera, T. Julian, G. Sledge, 2020 .

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.

M. Dowsett, T. Julian, M. Cheang, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.

Stewart J Anderson, Norman Wolmark, James J Dignam, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

T. Julian, D. Wickerham, N. Wolmark, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy

T. Julian, S. Paik, G. Tang, 2017, Journal of the National Cancer Institute.

Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS?

T. Julian, J. Costantino, N. Wolmark, 2007, Annals of Surgical Oncology.

Anti-HER2/neu Therapy in DCIS

T. Julian, K. Siziopikou, M. Cobleigh, 2015 .

Landmark Clinical Trials Influencing Surgical Management of Non‐invasive and Invasive Breast Cancer

T. Julian, Charis A. Venditti, Shivani Duggal, 2015, The breast journal.

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

W. Curran, M. Scheier, H. Kuerer, 2019, The Lancet.

Intracellular Patterns of Her-2/neu, ras, and Ploidy Abnormalities in Primary Human Breast Cancers Predict Postoperative Clinical Disease-Free Survival

R. Day, T. Julian, J. Silverman, 2004, Clinical Cancer Research.

Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?

A. Giuliano, T. Julian, M. Morrow, 2012, Clinical & Experimental Metastasis.

Contura Multi-Lumen Balloon breast brachytherapy catheter: comparative dosimetric findings of a phase 4 trial.

N. Mukhopadhyay, T. Julian, F. Vicini, 2013, International journal of radiation oncology, biology, physics.

Optimal application of the Contura multilumen balloon breast brachytherapy catheter vacuum port to deliver accelerated partial breast irradiation.

T. Julian, F. Vicini, K. Tokita, 2011, Brachytherapy.

Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.

N. Mukhopadhyay, T. Julian, F. Vicini, 2014, International journal of radiation oncology, biology, physics.

Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer.

Scott M Berry, Pat Whitworth, Donald A Berry, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer.

T. Julian, N. Wolmark, K. Jasnosz, 2001, American journal of surgery.

Technical Limitations of Sentinel Node Biopsy in Breast Cancer: A Single Surgeon's Experience

T. Julian, G. Bragdon, N. Patel, 2003, The American surgeon.

Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance)

K. Hunt, T. Julian, W. Symmans, 2017, Annals of surgery.

Complications of indwelling central venous catheters in bone marrow transplant recipients.

T. Julian, R. Shadduck, C. Rosenfeld, 1991, Surgery, gynecology & obstetrics.

Genital edema in patients on continuous ambulatory peritoneal dialysis. Report of 3 cases and review of the literature.

T. Julian, S. Adler, F. Bruns, 1986, American journal of nephrology.

REPAIRED BY LAPAROSCOPIC SURGERY

T. Julian, F. Bruns, D. Fraley, 1995 .

Laparoscopic approach for islet cell transplantation.

T. Julian, T. Starzl, C. Ricordi, 1992, Transplantation proceedings.

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

T. Julian, J. Costantino, N. Wolmark, 2016, The Lancet.

Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.

T. Julian, J. Kopec, N. Wolmark, 2012, The journal of supportive oncology.

Ductal carcinoma in situ: an overview

T. Julian, J. Robin, Shivani Duggal, 2013, Expert review of anticancer therapy.

Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

T. Julian, Hilary M Shapiro-Wright, 2010, Journal of the National Cancer Institute. Monographs.

Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer

D. Berry, E. Feuer, R. Gray, 2018, Journal of the National Cancer Institute.

Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial: A Randomized Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer

T. Julian, D. Weaver, D. Krag, 2005, Annals of surgery.

The Landmark Surgical Trials of the National Surgical Adjuvant Breast and Bowel Project

T. Julian, J. Costantino, D. Wickerham, 2006, World Journal of Surgery.

Mammographic density and breast cancer after ductal carcinoma in situ.

James J Dignam, T. Julian, L. Habel, 2004, Journal of the National Cancer Institute.

Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Results in Alterations in Preoperative Tumor Marker Status

T. Julian, G. Piper, N. Patel, 2004, The American surgeon.

Avoiding Mastectomy: Accelerated Partial Breast Irradiation for Breast Cancer Patients with Pacemakers or Defibrillators

T. Julian, Yongbok Kim, Randal L. Croshaw, 2011, Annals of Surgical Oncology.

Perioperative total parenteral nutrition in patients with gastrointestinal cancer.

T. Julian, J. Stremple, B. Thompson, 1981, The Journal of surgical research.

Microangiographic Study of Healing Wounds in Canine Intestinal Anastomoses

T. Julian, R. Kolachalam, 1989 .

The triple-stapled colonic anastomosis

T. Julian, R. Kolachalam, N. Wolmark, 1989, Diseases of the colon and rectum.

Treatment Volume Reduction using the Biozorb® Device in Ipsilateral Breast Recurrence Treated with Second Conservation Therapy

T. Julian, M. Trombetta, S. Hasan, 2017 .

Accuracy of Clinical Examination, Digital Mammogram, Ultrasound, and MRI in Determining Postneoadjuvant Pathologic Tumor Response in Operable Breast Cancer Patients

T. Julian, Randal L. Croshaw, Randal Croshaw, 2011, Annals of Surgical Oncology.

The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project.

T. Julian, N. Petrelli, S. Paik, 2008, Seminars in oncology.

Surgical Treatment for Women with Breast Cancer: Do Randomized Clinical Trials Represent Current Medical Practices?: Frederick WAI, Ames S, Downing SR, et al (Howard Univ College of Medicine, Washington, DC; et al) Am Surg 76:630-636, 2010 §

T. Julian, 2011 .

If sentinel node micrometastases are the question, are clinical trials the answer?

T. Julian, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of radiotherapy boost in women with ductal carcinoma in situ: A single-center experience in a series of 389 patients: Meattini I, Livi L, Franceschini D, et al (Univ of Florence, Italy; et al) Eur J Surg Oncol 39:613-618, 2013§

T. Julian, J. Robin, Amelia Tower, 2013 .

Laparoscopic removal of a displaced ventriculoperitoneal shunt.

T. Julian, U. Ribeiro, 1995, Journal of laparoendoscopic surgery.

Is excision alone adequate for low-risk DCIS of the breast treated with breast conserving therapy

T. Julian, F. Vicini, Atif J. Khan, 2014, Journal of Radiation Oncology.

Racial disparity in distant recurrence-free survival in localized breast cancer patients: A pooled analysis of NSABP trials

T. Julian, J. Sparano, J. Condeelis, 2021, medRxiv.

Surveillance Mammography After Breast Conservation Therapy

T. Julian, M. Trombetta, Matthew Bigbee, 2019, American journal of clinical oncology.

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor – Positive Early Breast Cancer

Maggie, Morden., M. Dowsett, 2019 .

Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients

T. Julian, F. Vicini, N. Goldstein, 2015, American journal of clinical oncology.

Accurate Axillary Nodal Staging Can be Achieved after Neoadjuvant Therapy for Locally Advanced Breast Cancer

T. Julian, G. Piper, N. Patel, 2004, The American surgeon.

NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer.

R. Jagsi, T. Julian, R. Zellars, 2022, Journal of Clinical Oncology.

Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial

G. Gustafson, T. Julian, F. Vicini, 2019, International Journal of Radiation Oncology*Biology*Physics.

NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial

Donald L. Weaver, Richard M. Single, David N. Krag, 2004, Annals of Surgical Oncology.

The Need for Axillary Dissection in Patients with Positive Axillary Sentinel Lymph Nodes

T. Julian, Randal L. Croshaw, K. Erb, 2011, Current oncology reports.

Shortened Radiation Therapy Schedules for Early‐Stage Breast Cancer: A Review of Hypofractionated Whole‐Breast Irradiation and Accelerated Partial Breast Irradiation

W. Woodward, G. Babiera, T. Julian, 2014, The breast journal.

Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.

T. Julian, M. Miften, D. Parda, 2008, Brachytherapy.

Partial Breast Irradiation: Continuing the Retreat from Halstedian Breast Cancer Management

T. Julian, E. Mamounas, 2006 .

Ductal carcinoma in situ: a rose by any other name.

T. Julian, D. Wickerham, 2013, Journal of the National Cancer Institute.

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ.

T. Julian, Shivani Duggal, 2013, Journal of the National Cancer Institute.

a Multigene Expression a ssay to Predict l ocal r ecurrence r isk for d uctal Carcinoma i n Situ

T. Julian, Shivani Duggal, 2013 .

Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer.

T. Julian, N. Wolmark, D. Dusi, 2002, American journal of surgery.

Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer

T. Julian, D. Weaver, D. Krag, 2006, Cancer.

MRI: A role in clinical trials

T. Julian, 2001, Journal of magnetic resonance imaging : JMRI.

Correlations Among p 53 , Her-2 / neu , and ras Overexpression and Aneuploidy by Multiparameter Flow Cytometry in Human Breast Cancer : Evidence for a Common Phenotypic Evolutionary Pattern in Infiltrating Ductal Carcinomas 1

T. Julian, N. Wolmark, L. Gu, 2000 .

ductal Carcinoma in Situ: a r ose by any o ther Name

T. Julian, D. Wickerham, 2013 .

Management trends and outcomes of breast angiosarcoma: Is breast conservation feasible?

T. Julian, V. Verma, M. Trombetta, 2019, The breast journal.

The ongoing evaluation and evolution of breast cancer surgical care

T. Julian, Marielle Ferstenberg, 2020, The breast journal.

Completion of axillary dissection for a positive sentinel node: Necessary or not?

T. Julian, K. Erb, 2009, Current oncology reports.

Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).

T. Julian, C. Geyer, D. Wickerham, 2017, Chinese clinical oncology.

Long-term follow-up post-cryosurgery in a sheep breast model.

Y Rabin, T. Julian, N. Wolmark, 1999, Cryobiology.

Development of a cryosurgical technique for breast malignancies

Yoed Rabin, Thomas B. Julian, Peter Olson, 1999, Photonics West - Biomedical Optics.

Closure of the Urinary Bladder with Stainless Steel and Absorbable Staples

T. Julian, M. Ravitch, 1986, Annals of Surgery.

Partial-Breast Irradiation: Review of Modern Trials

T. Julian, F. Vicini, C. Shah, 2019, Current Breast Cancer Reports.

Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Results in Alterations in Preoperative Tumor Marker Status

T. Julian, G. Piper, N. Patel, 2022 .

Primary results of NRG Oncology / NSABP B-43: Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) with RT alone for women with HER2-positive ductal carcinoma in situ (DCIS) after lumpectomy.

T. Julian, N. Wolmark, K. Siziopikou, 2020 .

MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer.

C. Gatsonis, C. Lehman, C. Kuhl, 2007, The New England journal of medicine.

Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors.

R. Simmons, A. Giuliano, T. Julian, 2007, American Journal of Surgery.

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

T. Julian, J. Costantino, N. Wolmark, 2016, The Lancet.

Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches.

T. Julian, J. Costantino, N. Wolmark, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NSABP FB-6: Phase II trial of weekly paclitaxel (WP) and pazopanib following doxorubicin and cyclophosphamide (AC) as neoadjuvant therapy for HER2-negative locally advanced breast cancer (LABC).

M. Buyse, T. Julian, S. Paik, 2012 .

The use of the MammoSite balloon applicator in re-irradiation of the breast.

T. Julian, Yongbok Kim, M. Miften, 2008, Brachytherapy.